Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 122852-42-0

Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of alosetron during breastfeeding. Because of relatively high protein binding and only moderate bioavailability, exposure of the breastfed infant is likely to be low. Until more data are available, alosetron should only be used with careful infant monitoring during breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Alosetron
CAS Registry Number
122852-42-0
Drug Class
- Breast Feeding
- Gastrointestinal Agents
- Serotonin Antagonists
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Lamivudine.[Drugs and Lactation Database (...]Review Lamivudine.. Drugs and Lactation Database (LactMed®). 2006
- Review Lovastatin.[Drugs and Lactation Database (...]Review Lovastatin.. Drugs and Lactation Database (LactMed®). 2006
- Review Melatonin.[Drugs and Lactation Database (...]Review Melatonin.. Drugs and Lactation Database (LactMed®). 2006
- [Guidelines for the prevention and management of bronchial asthma (2024 edition)].[Zhonghua Jie He He Hu Xi Za Zh...][Guidelines for the prevention and management of bronchial asthma (2024 edition)].Chinese Thoracic Society, Chinese Medical Association. Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12; 48(3):208-248.
- Iodine supplementation for women during the preconception, pregnancy and postpartum period.[Cochrane Database Syst Rev. 2017]Iodine supplementation for women during the preconception, pregnancy and postpartum period.Harding KB, Peña-Rosas JP, Webster AC, Yap CM, Payne BA, Ota E, De-Regil LM. Cochrane Database Syst Rev. 2017 Mar 5; 3(3):CD011761. Epub 2017 Mar 5.
- Alosetron - Drugs and Lactation Database (LactMed®)Alosetron - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...